Drug Shortage Report for NOZINAN INJ 25MG/ML

Last updated on 2022-05-14 History
Report ID 152693
Drug Identification Number 01927698
Brand name NOZINAN INJ 25MG/ML
Common or Proper name Nozinan
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) METHOTRIMEPRAZINE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10
ATC code N05AA
ATC description ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-01-12
Estimated end date 2022-05-16
Actual end date 2022-05-13
Shortage status Resolved
Updated date 2022-05-14
Company comments Lots received are not releasable at this time. Intermittent supply available. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status Yes
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-01-13 English Compare
v2 2022-01-13 English Compare
v3 2022-01-13 French Compare
v4 2022-02-04 English Compare
v5 2022-02-04 English Compare
v6 2022-02-04 French Compare
v7 2022-02-04 English Compare
v8 2022-02-04 French Compare
v9 2022-02-21 English Compare
v10 2022-04-11 English Compare
v11 2022-04-11 French Compare
v12 2022-05-13 English Compare
v13 2022-05-13 French Compare
v14 2022-05-14 English Compare

Showing 1 to 14 of 14